| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chairman &CEO | CEO +4 more
2 companies
Seth Sandesh serves as a Chief Executive Officer at ATNM and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 25 buys and 0 sells. Those positions are worth an estimated $415K at current prices.
The biggest single holding is RLMD (~$415K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 20,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2018 | ATNM Actinium Pharmaceuticals, Inc. | Chairman &CEO | Buy | 10,000 | $0.44 | $4,372.00 | +7.0% | |
| Jul 17, 2018 | ATNM Actinium Pharmaceuticals, Inc. | CEO | Buy | 10,000 | $0.79 | $7,900.00 | +7.5% | |
| Apr 19, 2018 | ATNM Actinium Pharmaceuticals, Inc. | Chairman &CEO | Buy | 5,000 | $0.38 | $1,900.00 | +3.9% | |
| Aug 2, 2017 | ATNM Actinium Pharmaceuticals, Inc. | Chairman &CEO | Buy | 33,333 | $0.75 | $24,999.75 | +78.4% | |
| Jun 15, 2017 | ATNM Actinium Pharmaceuticals, Inc. | Chairman And CEO | Buy | 7,500 | $1.16 | $8,725.00 | +21.4% | |
| Dec 30, 2016 | ATNM Actinium Pharmaceuticals, Inc. | Executive Chairman | Buy | 5,000 | $0.88 | $4,400.00 | +16.7% | |
| Dec 12, 2016 | ATNM Actinium Pharmaceuticals, Inc. | Executive Chairman | Buy | 5,000 | $0.98 | $4,900.00 | +20.0% | |
| Apr 18, 2016 | ATNM Actinium Pharmaceuticals, Inc. | Director, Executive Chairman | Buy | 15,000 | $1.99 | $29,900.00 | +150.0% | |
| Dec 15, 2015 | RLMD Relmada Therapeutics, Inc. | Director | Buy | 9,500 | $3.19 | $30,313.00 | +8.4% | |
| Dec 14, 2015 | RLMD Relmada Therapeutics, Inc. | Director | Buy | 10,500 | $2.93 | $30,728.40 | +10.2% |